BioCopy AG and Immatics enter into a collaboration to characterize T cell receptor - peptide-HLA interactions

BASEL, Switzerland and TÜBINGEN, Germany, July 7, 2021 /PRNewswire/ -- BioCopy AG announces a collaboration with Immatics N.V. (NASDAQ: IMTX) "Immatics" in the field of characterization of T cell receptors (TCRs). T cell receptors and their interactions with peptide-HLA complexes (human...

from PR Newswire: https://ift.tt/2SQPVeb